
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Pharmacol. , 14 October 2022
Sec. Drug Metabolism and Transport
Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1051794
This article is a correction to:
Impact of Sampling Time Variability on Tacrolimus Dosage Regimen in Pediatric Primary Nephrotic Syndrome: Single-Center, Prospective, Observational Study
A Corrigendum on
Impact of sampling time variability on tacrolimus dosage regimen in pediatric primary nephrotic syndrome: single-center, prospective, observational study
by Huang L, Wang J, Yang J, Zhang H, Hu Y, Miao J, Mao J and Fang L (2022). Front. Pharmacol. 12:726667. doi: 10.3389/fphar.2021.726667
In the published article, there was an error in Affiliations 1, 2, 3.
In affiliation 1, instead of “Department of Pharmacy, The Children’s Hospital, National Clinical Research Center for Child Health, Zhejiang University School of Medicine, Hangzhou, China”, it should be “Department of Pharmacy, The Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China”.
In affiliation 2, instead of “Department of Nephrology, The Children’s Hospital, National Clinical Research Center for Child Health, Zhejiang University School of Medicine, Hangzhou, China”, it should be “Department of Nephrology, The Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China”.
In affiliation 3, instead of “Department of Pharmacy, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China”, it should be “Department of Pharmacy, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: sampling time, therapeutic drug monitoring, tacrolimus, nephrotic syndrome, pediatrics
Citation: Huang L, Wang J, Yang J, Zhang H, Hu Y, Miao J, Mao J and Fang L (2022) Corrigendum: Impact of sampling time variability on tacrolimus dosage regimen in pediatric primary nephrotic syndrome: Single-center, prospective, observational study. Front. Pharmacol. 13:1051794. doi: 10.3389/fphar.2022.1051794
Received: 23 September 2022; Accepted: 29 September 2022;
Published: 14 October 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Huang, Wang, Yang, Zhang, Hu, Miao, Mao and Fang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Luo Fang, ZmFuZ2x1b0B6amNjLm9yZy5jbg==; Jianhua Mao, bWFvamg4OEBnbWFpbC5jb20=
†These authors have contributed equally to this work
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.